Company profile: Genos
1.1 - Company Overview
Company description
- Provider of a revolutionary approach that brings DNA ownership into your hands and keeps genomic data actionable by connecting you with trusted partners to learn about yourself, help your community, and drive research to better human health.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genos
Denali Therapeutics
HQ: United States
Website
- Description: Provider of investigational therapeutics focused on neurodegenerative diseases, including BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease, DNL343 for ALS, SAR443820/DNL788 (RIPK1-targeting) for multiple sclerosis, and TAK-594/DNL593 (PTV:PGRN) for frontotemporal dementia–granulin, as well as DNL310 (ETV:IDS) for Hunter syndrome and DNL126 (ETV:SGSH) for MPS IIIA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Denali Therapeutics company profile →
Universal DX
HQ: Spain
Website
- Description: Provider of minimally invasive, blood-based in-vitro diagnostics for early cancer detection, including Signal-C®, a high-sensitivity and specificity test for colorectal cancer and advanced adenomas. Offers a multi-omics approach to identify pre-cancer and early-stage cancers, clinical trial collaborations, biorepository management, full-stack application development, and IEC 62304 software testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Universal DX company profile →
Veritas Intercontinental
HQ: Spain
Website
- Description: Provider of whole genome sequencing and interpretation for consumers and physicians, offering myGenome for disease prevention and healthcare management, myPrenatal non-invasive prenatal testing, myNewborn screening for early childhood onset diseases, hereditary cardiovascular and cancer risk genetic testing, and whole genome and exome sequencing for complex cases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veritas Intercontinental company profile →
Presidio Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel therapeutics for viral infections, including HCV and HIV, discovering, developing, and commercializing treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Presidio Pharmaceuticals company profile →
Ovation Fertility
HQ: United States
Website
- Description: Provider of assisted reproductive technology through a network of IVF and genetics labs, offering comprehensive IVF and andrology lab services; frozen donor eggs; surrogacy services matching intended parents with pre-screened gestational carriers; long-term storage of eggs, sperm, and embryos; preconception carrier screening and PGT; and off-site lab direction for IVF labs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ovation Fertility company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genos
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genos
2.2 - Growth funds investing in similar companies to Genos
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genos
4.2 - Public trading comparable groups for Genos
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →